Deals
CI Capital Partners, a New York-based private equity firm, has formed a partnership with Martin Reidy to jointly pursue platform company investments in the marketing services industry. Reidy brings has significant operational experience in marketing services, having most recently served as the President & CEO of Ansira, a leading technology-enabled marketing solutions provider focused on targeted local marketing. Prior to Ansira, he was Senior Partner at MediaLink and before that, President & CEO of Meredith Integrated Marketing. Reidy also served as President & CEO of both Publicis Modem Digitas and R/GA, two global marketing services agencies.
CI Capital and Reidy will
Liki24, a Ukraine-based e-commerce platform for medicine delivery, has raised a USD5 million round from Horizon Capital and existing investors, bringing total funding raised to date to USD6 million. This new equity round will support the Company’s ambitious European expansion plans, with Poland being the first international market where Liki24 launched operations last month.
Liki24.com is a marketplace aggregating offers from thousands of pharmacies and facilitating transactions between pharmacies and consumers. Liki24 launched in Ukraine in late 2017, addressing three consumer pain points: significant variation in pricing among market players, limited availability of medicines in one point of sale, and lack
PitchBook Data has released its healthcare focused Q2 European M&A Report, showing European M&A totalled an impressive EUR563.6 billion in H1 2020, keeping pace with 2019 figures despite the pandemic.
Parabellum Investments, an international investment firm specialising in the mid- market, has acquired the India business of The Column Group a US-based privately-owned technology consulting, systems, and services provider it acquired with The Acacia Group earlier this year.Based in Pune, Column India has a workforce of around 180 people and has a strong heritage providing IT services to international corporate clients. The company specialises in implementing BMC projects and solutions, in areas including cloud computing, IT service management and operations, and had revenues of around USD5million in its last financial year.
Parabellum Investments intends for Column India to work alongside
TA Associates, a global growth private equity firm, has signed a definitive agreement to make a strategic growth investment in Ivanti, a provider of enterprise-grade intelligent IT management and security software solutions.TA will join existing investor Clearlake Capital Group, as institutional shareholders in Ivanti.
The funding will provide additional capital that will enable Ivanti to increase its investment in innovation, accelerate its global growth and continue its acquisition strategy. The company will continue to be led by CEO Jim Schaper and the current management team. Terms of the transaction have not been disclosed.
Ivanti provides solutions that automate
Onecom, a UK-based independent business telecommunications provider backed by LDC and Ares Management Corporation, has acquired the Glamorgan Telecom Group for an undisclosed sum as part of an ambitious strategy designed to significantly expand the business over the next three years.The acquisition will see the multi-million-pound revenue Glamorgan Telecom Group become a Onecom company with its senior leadership, including chief executive officer Kelly Bolderson, remaining with the business. The deal represents the first of a number of acquisitions planned by Onecom, led by former O2 executive Ben Dowd, after it secured a GBP100 million funding package from LDC and Ares
Edtech startup BibliU has raised GBP500,000 as part of a Series A extension funding round, supported by Angel Investment Network (AIN), the world’s largest online angel investment platform. London-based BibliU is a digital education platform that provides students with digital access to their textbooks and libraries across all their devices. The campaign funding round, an addition to its GBP6.5 million Series A, was in response to a surge in demand due to Covid-19. Completed in eight weeks, the funds will be used for new technical hires to support demand from Universities. The startup is scaling rapidly with 60-plus new pilots across
Gaming quality assurance and testing firm Testronic, part of the Catalis Group, has acquired Whyttest, a games QA and customer support business headquartered in Romania – a move set to increase headcount by 15 per cent. Testronic provides services to the global games publishing and film and TV markets, including Quality Assurance, Localisation, Compliance and Certification and Customer Support. It employs over 1,000 people in the US, UK and Poland.
Whyttest was founded in Romania in 2014. Its 150-strong team provide mobile, PC and console video games testing at sites in Bucharest and Belgrade.
The deal provides additional capacity
A Corby care service for adults with learning disabilities has secured a GBP200k loan from the Midlands Engine Investment Fund (MEIF) Debt Finance, managed by Maven Capital Partners.The funding will enable BDC Healthcare & Education to purchase a new care facility in Northamptonshire while also creating several employment opportunities.
BDC is a care service for adults with learning difficulties and disabilities ranging from brain injuries, autism, ADHD, dyslexia and dyspraxia. Service users’ ages can range from mid-teens to mid-60s, with BDC providing sensory activities, real work skills, travel training and other life skills.
Shoaib Arshid, Managing Director at
Venture capital firm Advent Life Sciences has sold its portfolio company, KaNDy Therapeutics (KaNDy), to Bayer AG for an upfront consideration of USD425 million plus potential milestone payments of up to USD 450 million until launch followed by potential additional triple digit million sales milestones payments.KaNDy recently completed the Phase IIb with NT-814, a first in class, non-hormonal, once-daily, oral neurokinin-1,3 receptor antagonist, publishing positive data for the treatment of frequent symptoms of the menopause, hot flashes and night sweats (vasomotor symptoms). The start of Phase III clinical trial is expected to commence in 2021. Once the deal completes, Bayer
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
